| Ident. | Authors (with country if any) | Title |
|---|
| 000525 (2019) |
Marine Ibranosyan [France] ; Laetitia Beraud [France] ; Hélène Lemaire [France] ; Anne-Gaëlle Ranc [France] ; Christophe Ginevra [France] ; Sophie Jarraud [France] ; Ghislaine Descours [France] | The clinical presentation of Legionella arthritis reveals the mode of infection and the bacterial species: case report and literature review |
| 000635 (2019) |
Majed Khraishi ; Brad Millson ; John Woolcott [États-Unis] ; Heather Jones [États-Unis] ; Lisa Marshall [États-Unis] ; Nicolino Ruperto [Italie] | Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis |
| 000798 (2019) |
Elisa Gremese ; Stefano Alivernini ; Barbara Tolusso ; Martin P. Zeidler ; Gianfranco Ferraccioli | JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy |
| 000858 (2019) |
Shuntaro Saito ; Tsutomu Takeuchi | Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients |
| 000927 (2019) |
Uwe Wollina [Allemagne] ; Gesina Hansel [Allemagne] ; Jacqueline Schönlebe [Allemagne] ; Birgit Heinig [Allemagne] ; Ivanka Temelkova [Bulgarie] ; Georgi Tchernev [Bulgarie] ; Aleksandra Vojvocic [Serbie] ; Torello Lotti [Italie] | Eosinophilic Fasciitis – Report of Three Cases and Review of the Literature |
| 000977 (2019) |
Gabriella Giancane [Italie] ; Valentina Muratore [Italie] ; Valentina Marzetti [Italie] ; Neus Quilis [Italie] ; Belen Serrano Benavente [Italie] ; Francesca Bagnasco [Italie] ; Alessandra Alongi [Italie] ; Adele Civino [Italie] ; Lorenzo Quartulli [Italie] ; Alessandro Consolaro [Italie] ; Angelo Ravelli [Italie, Russie] | Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era |
| 000A10 (2019) |
Dipen Patel [États-Unis] ; Ahmed Shelbaya [États-Unis] ; Raymond Cheung [États-Unis] ; Jyoti Aggarwal [États-Unis] ; Sang Hee Park [États-Unis] ; Javier Coindreau [États-Unis] | Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis |
| 000C38 (2018) |
Leslie R. Harrold [États-Unis] ; George W. Reed [États-Unis] ; Jennie Best [États-Unis] ; Steve Zlotnick [États-Unis] ; Joel M. Kremer [États-Unis] | Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis |
| 000C43 (2018) |
Josef S. Smolen [Autriche] ; Annette Szumski [États-Unis] ; Andrew S. Koenig [États-Unis] ; Thomas V. Jones [États-Unis] ; Lisa Marshall [États-Unis] | Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial |
| 000C45 (2018) |
Joost Swart [Pays-Bas] ; Gabriella Giancane [Italie] ; Gerd Horneff [Allemagne] ; Bo Magnusson [Suède] ; Michael Hofer [Suisse] ; Katerina Alexeeva [Russie] ; Violeta Panaviene [Lituanie] ; Brigitte Bader-Meunier [France] ; Jordi Anton [Espagne] ; Susan Nielsen [Danemark] ; Fabrizio De Benedetti [Italie] ; Sylvia Kamphuis [Pays-Bas] ; Valda Sta Vi A ; Maria Tracahana [Grèce] ; Laura Marinela Ailioaie [Roumanie] ; Elena Tsitsami [Grèce] ; Ariane Klein [Allemagne] ; Kirsten Minden [Allemagne] ; Ivan Foeldvari [Allemagne] ; Johannes Peter Haas [Allemagne] ; Jens Klotsche [Allemagne] ; Anna Carin Horne [Suède] ; Alessandro Consolaro [Italie] ; Francesca Bovis [Italie] ; Francesca Bagnasco [Italie] ; Angela Pistorio [Italie] ; Alberto Martini [Italie] ; Nico Wulffraat [Pays-Bas] ; Nicolino Ruperto [Italie] | Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries |
| 000C73 (2018) |
Mathilde Bahuaud [France] ; Constance Beaudouin-Bazire [France] ; Marine Husson [France] ; Anna Molto [France] ; Odile Launay [France] ; Frédéric Batteux [France] ; Maxime Dougados [France] | Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis |
| 000D19 (2018) |
Rieke Alten [Allemagne] ; Harald Burkhardt [Allemagne] ; Eugen Feist [Allemagne] ; Klaus Krüger [Allemagne] ; Juergen Rech [Allemagne] ; Andrea Rubbert-Roth [Allemagne] ; Reinhard E. Voll [Allemagne] ; Yedid Elbez [France] ; Christiane Rauch [Allemagne] | Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting |
| 000D38 (2017) |
Ariane L. Herrick [Royaume-Uni] ; Xiaoyan Pan [Royaume-Uni] ; Sébastien Peytrignet [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Roger Hesselstrand [Suède] ; Luc Mouthon [France] ; Alan Silman [Royaume-Uni] ; Edith Brown [Royaume-Uni] ; Lászl Czirják [Hongrie] ; Jörg H W. Distler [Allemagne] ; Oliver Distler [Suisse] ; Kim Fligelstone [Royaume-Uni] ; William J. Gregory [Royaume-Uni] ; Rachel Ochiel [Royaume-Uni] ; Madelon Vonk [Pays-Bas] ; Codrina Ancu A [Roumanie] ; Voon H. Ong [Royaume-Uni] ; Dominique Farge [France] ; Marie Hudson [Canada] ; Marco Matucci-Cerinic [Italie] ; Alexandra Balbir-Gurman [Israël] ; Yvind Midtvedt [Norvège] ; Alison C. Jordan [Royaume-Uni] ; Paresh Jobanputra [Royaume-Uni] ; Wendy Stevens [Australie] ; Pia Moinzadeh [Allemagne] ; Frances C. Hall [Royaume-Uni] ; Christian Agard [France] ; Marina E. Anderson [Royaume-Uni] ; Elisabeth Diot [France] ; Rajan Madhok [Royaume-Uni] ; Mohammed Akil [Royaume-Uni] ; Maya H. Buch [Royaume-Uni] ; Lorinda Chung [États-Unis] ; Nemanja Damjanov [Serbie] ; Harsha Gunawardena [Royaume-Uni] ; Peter Lanyon [Royaume-Uni] ; Yasmeen Ahmad [Royaume-Uni] ; Kuntal Chakravarty [Royaume-Uni] ; S Ren Jacobsen [Danemark] ; Alexander J. Macgregor [Royaume-Uni] ; Neil Mchugh [Royaume-Uni] ; Ulf Müller-Ladner [Allemagne] ; Gabriela Riemekasten [Allemagne] ; Michael Becker [Allemagne] ; Janet Roddy [Australie] ; Patricia E. Carreira [Espagne] ; Anne Laure Fauchais [France] ; Eric Hachulla [France] ; Jennifer Hamilton [Royaume-Uni] ; Murat Nanç [Turquie] ; John S. Mclaren [Royaume-Uni] ; Jacob M. Van Laar [Pays-Bas] ; Sanjay Pathare [Royaume-Uni] ; Susannah Proudman ; Anna Rudin [Suède] ; Joanne Sahhar [Australie] ; Brigitte Coppere [France] ; Christine Serratrice [France] ; Tom Sheeran [Royaume-Uni] ; Douglas J. Veale [Irlande (pays)] ; Claire Grange [France] ; Georges-Selim Trad [France] ; Christopher P. Denton [Royaume-Uni] | Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS) |
| 000D80 (2017) |
Claire Baradat [France] ; Yannick Degboé [France] ; Arnaud Constantin [France] ; Alain Cantagrel [France] ; Adeline Ruyssen-Witrand [France] | No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysis |
| 000E17 (2017) |
Vicente Ruiz Garcia ; Amanda Burls ; Juan B. Cabello ; Paloma Vela Casasempere ; Sylvia Bort-Marti ; José A. Bernal | Certolizumab pegol (CDP870) for rheumatoid arthritis in adults |
| 000F62 (2015) |
Clara Leroy [France] ; Jean-Marc Rigot [France] ; Maryse Leroy [France] ; Christine Decanter [France] ; Kristell Le Mapihan [France] ; Anne-Sophie Parent [France] ; Anne-Claire Le Guillou [France] ; Ibrahim Yakoub-Agha [France] ; Sébastien Dharancy [France] ; Christian Noel [France] ; Marie-Christine Vantyghem [France] | Immunosuppressive drugs and fertility |
| 001043 (2014) |
Paul Emery [Royaume-Uni] ; Gerd R. Burmester [Allemagne] ; Vivian P. Bykerk [États-Unis] ; Bernard G. Combe [France] ; Daniel E. Furst [États-Unis] ; Emilie Barré [Belgique] ; Chetan S. Karyekar [États-Unis] ; Dennis A. Wong [États-Unis] ; Tom W J. Huizinga [Pays-Bas] | Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period |
| 001052 (2014) |
Bara Erhayiem [Royaume-Uni] ; Sue Pavitt [Royaume-Uni] ; Paul Baxter [Royaume-Uni] ; Jacqueline Andrews ; John P. Greenwood [Royaume-Uni] ; Maya H. Buch ; Sven Plein [Royaume-Uni] | Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial |
| 001055 (2014) |
Maxime Dougados [France] ; Karsten Kissel [Australie] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin Mola [Espagne] ; Georg Schett [Allemagne] ; Roberto Gerli [Italie] ; Michael Sejer Hansen [Danemark] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Corrado Bernasconi [Suisse] ; T W J. Huizinga [Pays-Bas] | Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study |
| 001056 (2014) |
T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi ; Corrado Bernasconi ; Maxime Dougados [France] | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
